Seizures & Epilepsy in Dogs: Medications, Monitoring & Management — Pet Health Pharmacy

Seizures are one of the most common neurological conditions in dogs, and epilepsy — recurrent seizures without an identifiable underlying structural or metabolic cause — is the most frequently diagnosed chronic neurological disorder in canine medicine. Witnessing a seizure in your dog is frightening, but the majority of epileptic dogs can be well controlled with appropriate anticonvulsant medication and regular veterinary monitoring. Understanding the types of seizures, available medications, and the importance of consistent treatment helps you work effectively with your veterinarian to give your dog the best possible quality of life.

Overview

A seizure is a sudden, uncontrolled burst of abnormal electrical activity in the brain. In dogs, seizures are broadly classified by their underlying cause:

Idiopathic epilepsy — The most common cause of seizures in dogs aged 1-5 years. No structural brain lesion or metabolic cause can be identified. Idiopathic epilepsy is believed to have a genetic basis in many breeds, including Labrador Retrievers, Golden Retrievers, German Shepherds, Beagles, Belgian Tervurens, Bernese Mountain Dogs, and Australian Shepherds.
Structural epilepsy — Seizures caused by an identifiable brain abnormality, such as a brain tumor, encephalitis (brain inflammation), hydrocephalus, or stroke. These causes are more common in dogs under 1 year or over 5 years at first seizure onset.
Reactive seizures — Seizures caused by metabolic disturbances outside the brain, such as hypoglycemia (low blood sugar), liver disease (hepatic encephalopathy), toxin ingestion (including xylitol, chocolate, and certain plants), kidney failure, or electrolyte abnormalities. Treating the underlying cause typically resolves the seizures.

Understanding which category applies to your dog is important because it determines both the treatment approach and the prognosis. Idiopathic epilepsy is the focus of this page, as it is the condition most commonly managed with long-term anticonvulsant medication.

Types of Seizures

Seizures in dogs present in several forms:

Generalized (Grand Mal) Seizures

The most common and recognizable type. The dog loses consciousness, falls to its side, and exhibits rhythmic paddling or jerking of the limbs, jaw chomping, excessive salivation, and sometimes urination or defecation. Most generalized seizures last 30 seconds to 2 minutes.

Focal (Partial) Seizures

These affect only one part of the brain and may cause twitching of one limb or side of the face, involuntary turning of the head, or behavioral changes (fly biting, staring, sudden aggression). The dog may or may not lose consciousness. Focal seizures can progress to generalized seizures.

Cluster Seizures

Two or more seizures occurring within a 24-hour period. Cluster seizures are a veterinary emergency and require immediate treatment, as each subsequent seizure increases brain temperature and the risk of brain damage.

Status Epilepticus

A seizure lasting longer than 5 minutes, or multiple seizures without full recovery of consciousness between episodes. Status epilepticus is a life-threatening emergency requiring immediate veterinary intervention to stop the seizure and prevent permanent brain damage or death.

Symptoms

Before a Seizure (Pre-ictal / Aura Phase)

Many dogs show behavioral changes minutes to hours before a seizure:

Restlessness, pacing, or anxiety
Seeking out the owner or hiding
Whining or vocalization
Excessive licking or salivation
Staring blankly

During a Seizure (Ictal Phase)

Loss of consciousness (generalized seizures)
Falling to one side and becoming rigid
Rhythmic jerking or paddling of the limbs
Jaw champing or chomping
Excessive drooling, foaming at the mouth
Urination and/or defecation
Vocalization (crying, howling — involuntary, not a sign of pain awareness)

After a Seizure (Post-ictal Phase)

The recovery period can last minutes to hours and may include:

Confusion and disorientation
Temporary blindness
Excessive thirst and hunger
Pacing or restlessness
Stumbling or ataxia (uncoordinated movement)
Exhaustion and prolonged sleep

Diagnosis

Diagnosing epilepsy in dogs is primarily a process of exclusion — ruling out metabolic, toxic, and structural causes of seizures:

Complete blood count and chemistry panel — Screens for metabolic causes including hypoglycemia, liver disease, kidney disease, and electrolyte imbalances.
Bile acid testing — Evaluates liver function, particularly to rule out portosystemic shunts (abnormal blood vessels that bypass the liver), which are a common cause of seizures in young dogs of certain breeds.
Thyroid testing — Hypothyroidism has been associated with seizure activity in some dogs, though the relationship remains debated.
Urinalysis — Part of the baseline health assessment.
Blood pressure measurement — Hypertension can occasionally contribute to seizure activity.
Advanced imaging (MRI) — The gold standard for evaluating brain structure. An MRI is recommended for dogs with their first seizure before age 1 or after age 5, dogs with abnormal neurological examination findings between seizures, or dogs whose seizures are not responding to standard medications. MRI requires general anesthesia and typically costs $1,500-3,000+.
Cerebrospinal fluid (CSF) analysis — Collected under anesthesia (often at the same time as MRI) to evaluate for encephalitis, meningitis, or other inflammatory brain conditions.
Toxicology screening — If toxin exposure is suspected.

A diagnosis of idiopathic epilepsy is made when a dog between ages 1 and 5 has recurrent seizures, a normal neurological examination between seizures, and no metabolic or structural cause is identified.

Treatment Options

When to Start Medication

Not every dog that has a seizure requires anticonvulsant medication. Your veterinarian will generally recommend starting treatment if:

Your dog has had two or more seizures within a 6-month period
Your dog has had cluster seizures or status epilepticus
The post-ictal phase is severe or prolonged
Seizures are increasing in frequency or severity
There is an identified structural brain lesion

Once anticonvulsant medication is started, it is typically a lifelong commitment. Abruptly discontinuing anticonvulsants can trigger severe rebound seizures, including status epilepticus. Never stop or adjust your dog’s seizure medication without veterinary guidance.

Medication Overview

Medication	Type	How It Works	Key Considerations
Phenobarbital	Barbiturate	Enhances GABA inhibition in the brain, raising the seizure threshold	First-line treatment for canine epilepsy. Effective in approximately 60-80% of dogs as monotherapy. Reaches steady state in 2-3 weeks. Requires regular blood level monitoring (therapeutic range: 20-35 mcg/mL). Can cause liver enzyme elevation and, with long-term use, hepatotoxicity. Common side effects: increased thirst, urination, appetite, and initial sedation (usually resolves in 1-2 weeks). DEA Schedule IV controlled substance.
Potassium bromide (KBr)	Halide salt	Competes with chloride ions at neuronal chloride channels, stabilizing neuronal membranes	Often used as add-on therapy with phenobarbital, or as monotherapy in dogs with liver disease (bromide is not metabolized by the liver — it is excreted by the kidneys). Very long half-life (25 days in dogs); takes 3-4 months to reach steady state (loading doses can accelerate this). Therapeutic range: 1,000-3,000 mcg/mL (monotherapy) or 1,000-2,000 mcg/mL (combined with phenobarbital). Side effects: sedation, hind-limb weakness, vomiting, increased appetite. Dietary salt changes affect bromide levels — must maintain consistent salt intake.
Levetiracetam (Keppra)	Novel anticonvulsant (SV2A modulator)	Binds synaptic vesicle protein SV2A, modulating neurotransmitter release	Increasingly popular due to an excellent safety profile and minimal liver metabolism. Effective as monotherapy in approximately 30-40% of dogs, but more commonly used as adjunctive therapy. Short half-life in dogs (approximately 3-4 hours) requires dosing every 8 hours — strict schedule adherence is critical. Extended-release formulation (Keppra XR) allows every-12-hour dosing but tablets cannot be split or crushed. Common side effects: mild sedation, decreased appetite (usually temporary). Important: phenobarbital increases the metabolism of levetiracetam, potentially requiring higher doses when used together.
Zonisamide	Sulfonamide anticonvulsant	Multiple mechanisms: blocks sodium and T-type calcium channels, enhances GABA, inhibits glutamate release	Approximately 60% effective as monotherapy. Longer half-life than levetiracetam (approximately 15 hours in dogs), allowing twice-daily dosing. Metabolized by the liver — phenobarbital can increase its metabolism when used concurrently. Sulfonamide structure means potential for rare idiosyncratic reactions (dry eye/KCS, liver toxicity). Monitor for decreased tear production. Side effects: sedation, decreased appetite, ataxia (usually mild and transient).

Combination Therapy

Many dogs with epilepsy require more than one medication to achieve adequate seizure control. Common combinations include:

Phenobarbital + potassium bromide — The most well-established combination; allows lower doses of each drug, potentially reducing side effects
Phenobarbital + levetiracetam — Note: phenobarbital increases levetiracetam metabolism; higher Keppra doses may be needed
Phenobarbital + zonisamide — Note: phenobarbital also increases zonisamide metabolism
Triple therapy — Some refractory cases require three medications

Your veterinarian will titrate doses based on seizure frequency, drug levels, and side effects. The goal is not necessarily to eliminate all seizures (which may not be possible), but to reduce seizure frequency and severity to an acceptable level with tolerable side effects.

Emergency Seizure Management at Home

If your dog has a seizure at home:

Stay calm. Note the time the seizure started.
Keep your hands away from the dog’s mouth. Dogs do not swallow their tongues. You risk being bitten.
Clear the area of furniture or objects that could injure the dog.
Do not restrain the dog. Gently guide the dog away from stairs or edges if possible.
Time the seizure. If it lasts more than 3 minutes, or if a second seizure begins before full recovery, this is an emergency — transport to a veterinarian immediately.
After the seizure, keep the environment quiet and dim. Offer water once the dog is alert and oriented.

Some dogs with a history of cluster seizures may be prescribed emergency medications to administer at home:

Rectal diazepam (Valium) — Administered rectally using a syringe without a needle; rapidly absorbed
Intranasal midazolam — Sprayed into the nostril; increasingly preferred due to ease of administration
Levetiracetam pulse dosing — An extra oral dose of levetiracetam given at the onset of a cluster event

Your veterinarian will provide specific instructions for when and how to administer emergency medications.

Monitoring

Dogs on anticonvulsant medications require regular veterinary monitoring:

Phenobarbital Monitoring

Blood drug levels — Check 2-3 weeks after starting or adjusting dose (steady state), then every 6 months. Therapeutic range: 20-35 mcg/mL.
Liver values — ALT, ALP, GGT, and bile acids every 6 months. Phenobarbital induces liver enzyme production, so mild ALP elevations are expected and do not necessarily indicate liver damage. However, progressive elevation or elevated bile acids may indicate hepatotoxicity.
Complete blood count — Every 6-12 months. Rarely, phenobarbital can cause bone marrow suppression.

Potassium Bromide Monitoring

Blood bromide levels — Check after reaching steady state (3-4 months, or 5-7 days after a loading dose), then every 6 months. Monitor dietary salt intake — changes in salt consumption alter bromide levels.
Kidney values — BUN and creatinine, since bromide is renally excreted.

Levetiracetam Monitoring

Trough levels — Can be measured, though routine monitoring is not universally performed due to the drug’s wide safety margin. Most useful when seizure control is inadequate.
Liver and kidney values — Baseline and annually, though levetiracetam has minimal organ toxicity.

Zonisamide Monitoring

Blood drug levels — Trough levels can be measured if seizure control is inadequate.
Schirmer tear test — To monitor for keratoconjunctivitis sicca (dry eye), a rare but documented side effect.
Liver values — Periodically, especially if used with phenobarbital.

Seizure Diary

Keeping a detailed seizure diary is one of the most valuable tools for managing canine epilepsy. Record:

Date and time of each seizure
Duration (seconds or minutes)
Type (generalized, focal, cluster)
Description of what you observed
Any potential triggers (stress, weather changes, missed medication)
Recovery time and behavior post-seizure
Any medication changes or missed doses

This information helps your veterinarian assess treatment efficacy and make informed dose adjustments.

Prognosis

The prognosis for dogs with idiopathic epilepsy varies based on seizure severity, response to medication, and the presence of complications:

Approximately 15-30% of epileptic dogs are considered “refractory” — they do not achieve adequate seizure control despite appropriate medication trials. These dogs may benefit from combination therapy, newer anticonvulsants, or referral to a veterinary neurologist.
Dogs that respond well to treatment can live normal or near-normal lifespans with good quality of life. Many epileptic dogs are well controlled on phenobarbital alone or in combination with one additional medication.
Cluster seizures and status epilepticus carry a more guarded prognosis and are associated with higher morbidity and mortality.
Breed-specific considerations — Some breeds (such as Border Collies and Australian Shepherds) may have more treatment-resistant forms of epilepsy.

The most important factors for a good outcome are early diagnosis, consistent medication administration, regular monitoring, and prompt treatment of breakthrough seizures or cluster events.

Frequently Asked Questions

Can epilepsy in dogs be cured?

Idiopathic epilepsy cannot be cured, but it can be effectively managed in the majority of dogs with anticonvulsant medication. The goal of treatment is to reduce seizure frequency and severity to an acceptable level. Some dogs become seizure-free on medication, while others have occasional breakthrough seizures that are less frequent and less severe than before treatment.

How much do seizure medications cost?

Costs vary significantly by medication and dog size. Phenobarbital is the most affordable option (typically $10-30 per month). Potassium bromide is similarly inexpensive. Levetiracetam (Keppra) is moderately priced ($30-80 per month, depending on dose and whether generic or brand-name is used). Zonisamide ranges from $30-60 per month. Blood monitoring adds $150-300 per visit, typically every 6 months.

Is it safe to give my dog phenobarbital long-term?

Phenobarbital has been used safely in dogs for decades and remains the first-line treatment for canine epilepsy. However, long-term use does carry a risk of hepatotoxicity (liver damage) in some dogs, which is why regular blood monitoring of liver values and drug levels is essential. Many dogs take phenobarbital for years without liver problems. If liver values become concerning, your veterinarian may transition to an alternative medication.

My dog had one seizure. Does that mean epilepsy?

Not necessarily. A single seizure does not constitute epilepsy. Epilepsy is defined as recurrent seizures. A single seizure may be caused by a toxin, metabolic disturbance, or other transient factor. However, one seizure does warrant a veterinary evaluation to rule out underlying causes. Your veterinarian may recommend monitoring rather than immediately starting medication after a first seizure.

Can I ever stop seizure medication?

In most cases, anticonvulsant medication is lifelong. Abruptly stopping seizure medication is dangerous and can trigger severe withdrawal seizures, including status epilepticus. If your veterinarian considers it appropriate (for example, if the dog has been seizure-free for an extended period and the original diagnosis is uncertain), medication may be very gradually tapered over months under close veterinary supervision. This is uncommon.

What triggers seizures in epileptic dogs?

Many seizures in epileptic dogs appear to occur without an identifiable trigger. However, some owners report that the following may lower their dog’s seizure threshold: stress or excitement, sleep deprivation, missed or late medication doses, changes in routine, weather changes (particularly barometric pressure drops), and hormonal fluctuations (in intact dogs).

Should I change my epileptic dog’s diet?

Some emerging research suggests that medium-chain triglyceride (MCT) supplementation may have anticonvulsant properties in dogs by providing an alternative brain energy source (ketone bodies). MCT-enriched diets (such as Purina Pro Plan Veterinary NC NeuroCare) are available by veterinary prescription. Discuss dietary options with your veterinarian, especially for dogs with refractory epilepsy. Importantly, if your dog is on potassium bromide, do not change dietary salt content without consulting your veterinarian, as salt intake directly affects bromide blood levels.

Sources & References

Merck Veterinary Manual: Seizures and Epilepsy in Dogs — Comprehensive clinical overview of diagnosis and treatment.
American Kennel Club Canine Health Foundation: Epilepsy in Dogs — Owner-focused educational resource on canine epilepsy.
VCA Animal Hospitals: Seizures in Dogs — Practical guide to seizure types, first aid, and medication options.
Podell M, Volk HA, Berendt M, et al. “2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs.” Journal of Veterinary Internal Medicine, 30(2):477-490, 2016. — Evidence-based consensus guidelines for veterinary professionals on diagnosis and treatment of canine epilepsy.
Charalambous M, Brodbelt D, Volk HA. “Treatment in canine epilepsy — a systematic review.” BMC Veterinary Research, 10:257, 2014. — Systematic review of anticonvulsant efficacy in dogs.
Munana KR, Thomas WB, Inzana KD, et al. “Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.” Journal of Veterinary Internal Medicine, 26(2):341-348, 2012. — Clinical trial demonstrating levetiracetam efficacy as add-on therapy.
Law TH, Davies ES, Pan Y, et al. “A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.” British Journal of Nutrition, 114(9):1438-1447, 2015. — Research on dietary MCT supplementation for canine epilepsy.
Dewey CW, Cerda-Gonzalez S, Levine JM, et al. “Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy.” Journal of the American Veterinary Medical Association, 235(12):1442-1449, 2009. — Study on combination therapy approaches.